Monitoring of T790M in Plasma Ctdna of Advanced EGFR-mutant NSCLC Patients on First- or Second-Generation Tyrosine Kinase Inhibitors.
BMC CANCER（2023）
Key words
Droplet digital polymerase chain reaction,EGFR mutation,Lung cancer,Osimertinib,Tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined